Obecabtagene autoleucel
AUTO1-SL2
Phase 2 mab active
Quick answer
Obecabtagene autoleucel for Lupus Nephritis is a Phase 2 program (mab) at Autolus Therapeutics plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Autolus Therapeutics plc
- Indication
- Lupus Nephritis
- Phase
- Phase 2
- Modality
- mab
- Status
- active